These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 19178890)
21. Stimulation of T-helper cell gamma interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge. Norimine J; Mosqueda J; Suarez C; Palmer GH; McElwain TF; Mbassa G; Brown WC Infect Immun; 2003 Sep; 71(9):5021-32. PubMed ID: 12933845 [TBL] [Abstract][Full Text] [Related]
22. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico. Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602 [TBL] [Abstract][Full Text] [Related]
23. Comparison of different direct diagnostic methods to identify Babesia bovis and Babesia bigemina in animals vaccinated with live attenuated parasites. Costa-Júnior LM; Rabelo EM; Martins Filho OA; Ribeiro MF Vet Parasitol; 2006 Jun; 139(1-3):231-6. PubMed ID: 16580136 [TBL] [Abstract][Full Text] [Related]
24. PCR-based detection of the transovarial transmission of Uruguayan Babesia bovis and Babesia bigemina vaccine strains. Gayo V; Romito M; Nel LH; Solari MA; Viljoen GJ Onderstepoort J Vet Res; 2003 Sep; 70(3):197-204. PubMed ID: 14621315 [TBL] [Abstract][Full Text] [Related]
25. Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium. Rojas-Martínez C; Rodríguez-Vivas RI; Millán JVF; Bautista-Garfias CR; Castañeda-Arriola RO; Lira-Amaya JJ; Urióstegui PV; Carrasco JJO; Martínez JAÁ Parasitol Int; 2018 Apr; 67(2):190-195. PubMed ID: 29155165 [TBL] [Abstract][Full Text] [Related]
26. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains. Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940 [TBL] [Abstract][Full Text] [Related]
27. Use of a monoclonal antibody against Babesia bovis merozoite surface antigen-2c for the development of a competitive ELISA test. Dominguez M; Zabal O; Wilkowsky S; Echaide I; Torioni de Echaide S; Asenzo G; Rodríguez A; Zamorano P; Farber M; Suarez C; Florin-Christensen M Ann N Y Acad Sci; 2004 Oct; 1026():165-70. PubMed ID: 15604488 [TBL] [Abstract][Full Text] [Related]
28. The development of a recombinant Babesia vaccine. Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189 [TBL] [Abstract][Full Text] [Related]
29. Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity. Shkap V; de Vos AJ; Zweygarth E; Jongejan F Trends Parasitol; 2007 Sep; 23(9):420-6. PubMed ID: 17656155 [TBL] [Abstract][Full Text] [Related]
30. Babesia bovis expresses a neutralization-sensitive antigen that contains a microneme adhesive repeat (MAR) domain. Silva MG; Ueti MW; Norimine J; Florin-Christensen M; Bastos RG; Goff WL; Brown WC; Oliva A; Suarez CE Parasitol Int; 2010 Jun; 59(2):294-7. PubMed ID: 20304092 [TBL] [Abstract][Full Text] [Related]
31. Failure of a recombinant Babesia bovis antigen to protect cattle against heterologous strain challenge. Timms P; Barry DN; Gill AC; Sharp PJ; de Vos AJ Res Vet Sci; 1988 Sep; 45(2):267-9. PubMed ID: 3194602 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of an Australian Babesia bovis vaccine strain in Malawi. Lawrence JA; Malika J; Whiteland AP; Kafuwa P Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344 [TBL] [Abstract][Full Text] [Related]
33. A conserved motif in the immune-subdominant RAP-1 related antigen of Rojas MJ; Bastos RG; Navas J; Laughery JM; Lacy PA; Suarez CE Front Immunol; 2024; 15():1380660. PubMed ID: 38720894 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen. Jaramillo Ortiz JM; Molinari MP; Gravisaco MJ; Paoletta MS; Montenegro VN; Wilkowsky SE Vaccine; 2016 Jul; 34(33):3913-9. PubMed ID: 27269058 [TBL] [Abstract][Full Text] [Related]
35. Bovine babesiosis: failure to induce interferon gamma production in response to Babesia bovis antigens in cattle. Orinda GO; Gale KR; Wright IG; Parrodi F Int J Parasitol; 1992 May; 22(3):395-8. PubMed ID: 1639576 [TBL] [Abstract][Full Text] [Related]
37. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens. Figueroa JV; Precigout E; Carcy B; Gorenflot A Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542 [TBL] [Abstract][Full Text] [Related]
38. Persistence of antibodies against epitopes encoded by a single gene copy of the Babesia bovis merozoite surface antigen 1 (MSA-1). McElwain TF; Hines SA; Palmer GH J Parasitol; 1998 Apr; 84(2):449-52. PubMed ID: 9576525 [TBL] [Abstract][Full Text] [Related]
39. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection. Brown WC Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299 [TBL] [Abstract][Full Text] [Related]
40. Successful vaccination against Boophilus microplus and Babesia bovis using recombinant antigens. Willadsen P; Kemp DH; Cobon GS; Wright IG Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():289-94. PubMed ID: 1343705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]